Edmond DE Rothschild Holding S.A. Trims Position in Doximity, Inc. (NASDAQ:DOCS)

Edmond DE Rothschild Holding S.A. lessened its stake in Doximity, Inc. (NASDAQ:DOCS) by 45.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 555,165 shares of the company’s stock after selling 467,004 shares during the period. Edmond DE Rothschild Holding S.A. owned 0.30% of Doximity worth $29,640,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DOCS. Thrivent Financial for Lutherans increased its holdings in shares of Doximity by 5.0% in the third quarter. Thrivent Financial for Lutherans now owns 30,991 shares of the company’s stock valued at $1,350,000 after purchasing an additional 1,474 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Doximity by 4.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 753,001 shares of the company’s stock valued at $32,808,000 after buying an additional 31,966 shares during the period. Cerity Partners LLC lifted its stake in shares of Doximity by 21.4% in the 3rd quarter. Cerity Partners LLC now owns 49,876 shares of the company’s stock worth $2,173,000 after acquiring an additional 8,781 shares during the period. FMR LLC boosted its holdings in shares of Doximity by 30.5% in the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after acquiring an additional 1,598,602 shares in the last quarter. Finally, MetLife Investment Management LLC increased its stake in shares of Doximity by 0.6% during the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock worth $2,835,000 after acquiring an additional 363 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

DOCS has been the topic of a number of analyst reports. Piper Sandler raised Doximity from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $31.00 to $78.00 in a report on Friday, February 7th. Leerink Partners raised Doximity from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $60.00 to $90.00 in a report on Friday, February 7th. Raymond James reissued an “outperform” rating and issued a $83.00 target price (up previously from $65.00) on shares of Doximity in a report on Friday, February 7th. The Goldman Sachs Group upped their price target on shares of Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Finally, Stephens started coverage on shares of Doximity in a research note on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price objective for the company. Eleven research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Doximity currently has an average rating of “Moderate Buy” and a consensus target price of $64.22.

Doximity Trading Down 3.6 %

Shares of DOCS stock opened at $58.40 on Monday. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The company has a market capitalization of $10.90 billion, a price-to-earnings ratio of 58.40, a PEG ratio of 4.10 and a beta of 1.34. The firm has a 50-day moving average price of $65.48 and a 200 day moving average price of $54.55.

Insider Activity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 37.40% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.